OncoMed says FDA lifts partial hold on cancer drug trials
August 28, 2014 at 08:50 AM EDT
Aug 28 (Reuters) - OncoMed Pharmaceuticals Inc said the U.S. Food and Drug Administration lifted a partial hold on patient enrolments for three trials testing its experimental cancer drug, vantictumab.
